NCT05718219 2025-08-13Safety, Tolerability, Pharmacokinetics and Preliminary Antitumor Activity of SIM0348 in Advanced Solid TumorsJiangsu Simcere Pharmaceutical Co., Ltd.Phase 1 Active not recruiting408 enrolled